22 employees
Genelabs Technologies is a biopharmaceutical company engaged in the R&D of therapeutics for the treatment of infectious diseases.
1983
$8.3M
from 2 investors over 2 rounds
Genelabs Technologies raised $8.3M on June 27, 2006
Investors: Centrecourt Asset Management and RA Capital Management, L.P.